TrianglePUBLICATIONS · 11313175
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer
- Publication date
- 2001 May
- First author
- Judson I
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Judson I
- type
- Author
- name
- Radford JA
- type
- Author
- name
- Harris M
- type
- Author
- name
- Blay JY
- type
- Author
- name
- van Hoesel Q
- type
- Author
- name
- le Cesne A
- type
- Author
- name
- van Oosterom AT
- type
- Author
- name
- Clemons MJ
- type
- Author
- name
- Kamby C
- type
- Author
- name
- Hermans C
- type
- Author
- name
- Whittaker J
- type
- Author
- name
- Donato di Paola E
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Judson I
- type
- Author
- name
- Radford JA
- type
- Author
- name
- Harris M
- type
- Author
- name
- Blay JY
- type
- Author
- name
- van Hoesel Q
- type
- Author
- name
- le Cesne A
- type
- Author
- name
- van Oosterom AT
- type
- Author
- name
- Clemons MJ
- type
- Author
- name
- Kamby C
- type
- Author
- name
- Hermans C
- type
- Author
- name
- Whittaker J
- type
- Author
- name
- Donato di Paola E
- type
- Author
- bibliography ids
- nci-bib-880687fc8fe11a9ffd2b781f
- book metadata
- content sha256
- a73098bf6595ca8be5a696e80f2420463796f2f4a2d6fa4b9c207f1b8a134d26
- document type
- citation
- dois
- 10.1016/s0959-8049(01)00050-8
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:11313175
- immutable id
- pubmed:11313175@a73098bf6595ca8be5a696e80f2420463796f2f4a2d6fa4b9c207f1b8a134d26
- journal
- abbreviation
- Eur J Cancer
- issn electronic
- Source null
- issn print
- 0959-8049
- issue
- 7
- name
- European journal of cancer (Oxford, England : 1990)
- nlm unique id
- 9005373
- pages
- 870-7
- volume
- 37
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 11313175
- provenance
- batch id
- 30d2cd7affbbb92b6784
- provider
- NCBI PubMed ESummary
- record sha256
- d929ce3ef5ff7eb2579e5a6c243c1e2a95576a11e2c8a149cbb15cc72dc65ca2
- response sha256
- ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
- retrieved at
- 2026-09-09T23:45:39.779418+00:00
- publication date
- display
- 2001 May
- precision
- month
- year
- 2001
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group.
Preserved source evidence · Not medical advice